|
[1]
|
Caroline JS,Ion ND.Prodrug-activating systems in suicide gene therapy.J Clin Invest,2000,105(9):1161-1167. |
|
[2]
|
Burrows FJ,Gore M,Smiley WR,et al.Purified herpes simplex virus thymidine kinase retroviral particles:Ⅲ.Characterization of bystander killing mechanisms in transfected tumor cells.Cancer Gene Ther,2002,9(1):87-95. |
|
[3]
|
Dilber MS,Gahrton G.Suicide gene therapy:possible applications in haematopoietic disorders.J Intern Med,2001,249(4):359-367. |
|
[4]
|
Hasenburg A,Tong XW,Rojas-Martinez A,et al.Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.Cancer Gene Ther,2000,7(6):839-844. |
|
[5]
|
Ayala G,Wheeler TM,Shalev M,et al.Cytopathic effect of in situ gene therapy in prostate cancer.Hum Pathol,2000,31(7):866-870. |
|
[6]
|
Shalev M,Kadmon D,Teh BS,et al.Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.J Urol,2000,163(6):1747-1750. |
|
[7]
|
Morris JC,Ramsey WJ,Wildner O,et al.A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma.Hum Gene Ther,2000,11(3):487-503. |
|
[8]
|
Buursma AR,van Dillen I J,van Waarde A,et al.Monitoring HSVtk suicide gene therapy:the role of[(18) F] FHPG membrane transport.Br J Cancer,2004,91(12):2079-2085. |
|
[9]
|
Alauddin MM,Shahinian A,Gordon EM,et al.Preclinical evaluation of the penciclovir analog 9-(4-[18F] fluoro-3-hydroxymethylbutyl) guanine for in vivo measurement of suicide gene expression with PET.J Nucl Med,2001,42(11):1682-1690. |
|
[10]
|
Iyer M,Barrio JR,Namavari M,et al.8-[18F] fluoropenciclovir:an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET.J Nucl Med,2001,42(8):96-105. |
|
[11]
|
Alauddin MM,Shahinian A,Gordon EM,et al.Evaluation of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) as a potential gene imaging agent for HSV-tk expression in vivo.Mol Imaging,2002,1(2):74-81. |
|
[12]
|
Tjuvajev JG,Doubrovin M,Akhurst T,et al.Direct comparison of HSV-tk PET imaging probes:FIAU,FHPG,FHBG.J Nucl Med,2002,43(8):1072-1083. |
|
[13]
|
Alauddin MM,Shahinian A,Park R,et al.Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.J Nucl Med,2004,45(12):2063-2069. |
|
[14]
|
Choi SR,Zhuang ZP,Chacko AM,et al.SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by[(123)I] FIAU.Acad Radiol,2005,12(7):798-805. |
|
[15]
|
Frank O,Rudolph C,Heberlein C,et al.Tumor cells escape suicide gene therapy by genetic and epigenetic instability.Blood,2004,104(12):3543-3549. |
|
[16]
|
Curiel DT.Strategies to adapt adenoviral vectors for targeted delivery.Ann NY Acad Sci,1999,886:158-171. |
|
[17]
|
Shillitoe EJ,Noonan S.Strength and specificity of different gene promoters in oral cancer cells.Oral Oncol,2000,36(2):214-220. |
DownLoad: